Doctor profile · Federal record
Dr. ALEXANDRA SCHERK, OD
Optometrist (CMS: OPTOMETRY) · GREAT NECK, NY
- NPI 1831683648
- Accepts Medicare
- MIPS 45.7 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
310 E SHORE RD STE 102
GREAT NECK, NY 110232432
(516) 466-8989
fax (516) 466-8962 - Additional location
-
1115 5th Ave
New York, NY 101280100
(212) 517-4500
fax (212) 517-4116 - Mailing address
-
215 E 95TH ST APT 17B
NEW YORK, NY 101280249
Credentials & registration
- NPI registered
- June 2018 — 8 yrs on file
- Profile last updated
- October 14, 2019
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 152W00000X — NUCC code
- State license (1)
- New York #TUV008796-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831683648. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,316
Distinct HCPCS
8
Medicare allowed
$130,502
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
92014 |
Established patient complete exam of visual system | 437 | 428 | $143 | |
92012 |
Established patient problem focused exam of visual system | 397 | 286 | $103 | |
83861 |
Microfluid analysis of tears | 206 | 87 | $22 | |
92133 |
Imaging of optic nerve | 94 | 93 | $41 | |
92004 |
New patient complete exam of visual system | 63 | 63 | $169 | |
92134 |
Imaging of retina | 49 | 42 | $46 | |
92083 |
Exam of visual field with extended testing | 44 | 41 | $72 | |
92002 |
New patient problem focused exam of visual system | 26 | 26 | $98 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 128. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$585
Transactions
21
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Oyster Point Pharma, Inc. | 11 | $191.94 | |
| Tarsus Pharmaceuticals, Inc. | 2 | $153.30 | |
| RxSight Inc | 1 | $97.91 | |
| Johnson & Johnson Vision Care, Inc. | 2 | $41.42 | |
| Bausch & Lomb Americas Inc. | 2 | $41.13 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35.95 | |
| Dompe US, Inc. | 1 | $23.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
564
Patients
171
Total drug cost
$234,571
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 150 | 30 | $2,214 |
| Restasis (Cyclosporine) | Brand | 93 | 37 | $144,223 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 71 | 49 | $1,017 |
| Lumigan (Bimatoprost) | Brand | 55 | 17 | $28,721 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 48 | 0 | $12,852 |
| Ofloxacin | Generic | 29 | 22 | $424 |
| Alphagan P (Brimonidine Tartrate) | Brand | 20 | 0 | $8,093 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 20 | 0 | $964 |
| Erythromycin (Erythromycin Base) | Brand | 20 | 16 | $192 |
| Zioptan (Tafluprost/Pf) | Brand | 17 | 0 | $5,366 |